Test Price
450 AED✅ Home Collection Available
Newborn Screening Panel 7 Test in Dubai | 450 AED | DNA Labs UAE
Executive Summary & Core Metrics
Clinical Excellence at Your Doorstep
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic post-test clinical guidance in result interpretation by a DHA-licensed general practitioner.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
- Data Privacy: All newborn health records secured under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Test Overview & Methodology
The Newborn Screening Panel 7 detects seven critical inborn errors of metabolism using a single heel-prick blood sample collected on filter paper. Our panel surpasses basic screening with confirmatory immunoassay precision and rapid next-day reporting, ensuring UAE newborns receive early intervention per DHA mandates.
| Feature | DNA Labs UAE | Alternative Standard Clinic |
|---|---|---|
| Precision | Time-resolved Fluoroimmunoassay (FEIA) with digital quantification | Basic colorimetric screening |
| Methodology | FEIA + confirmatory specialized immunoassays | Single immunoassay, no confirmation |
| Turnaround | Next-day report (Mon-Fri collection by 9 AM) | 2–5 working days |
| Home Collection | ISO‑certified cold‑chain home collection (8 AM–11 PM) | Often unavailable |
| Insurance Support | Direct billing verification + WhatsApp claims assistance | Manual process |
Physician Insight & Safety Protocols
“As a general practitioner with a focus on early childhood screening, I approach every newborn metabolic panel with careful attention. An abnormal result does not always indicate disease but must be correlated with clinical presentation and family history. Parents should never discontinue prescribed dietary formulas or supplements without consulting their physician.”
— Dr. Ajay Singh, General Practitioner (DHA Registration ID: 36234132)
Important Safety Notice
Do not discontinue prescribed medication or special dietary formulas without consulting your doctor. An abnormal result may require immediate confirmatory diagnostics, not abrupt cessation of treatment.
Exclusion Criteria for Home Collection
- Infant with critical illness or unstable vital signs — seek emergency care.
- Severe bleeding disorders or anticoagulant therapy (unless medically approved).
- Known allergy to latex or antiseptics used during heel prick.
ER Red Flags After Sample Collection:
- Persistent bleeding at puncture site exceeding 5 minutes.
- Signs of local infection (redness, swelling, fever).
- Sudden lethargy, poor feeding, or vomiting — immediate medical review.
Patient FAQ & Clinical Guidance
1. What diseases does the Newborn Screening Panel 7 detect?
The panel screens for seven critical inborn errors of metabolism that can cause severe neurological damage if left untreated, including phenylketonuria, maple syrup urine disease, and galactosemia. Early detection enables immediate dietary or medical intervention to prevent disability and death.
2. How should I prepare my baby for the heel-prick blood collection?
Ensure your newborn’s heel is warm to promote blood flow; no fasting is required, but inform our phlebotomist of any medications (including vitamin supplements) or clinical history. Our ISO-certified home collection team arrives with a sterile, single-use lancet and state-of-the-art cold chain transport.
3. How quickly will I receive the results, and who interprets them?
Results are delivered the next working day after sample receipt (Mon-Fri by 9 AM); a DHA-licensed general practitioner provides a telephonic consultation to explain findings, differentiate false positives, and recommend any urgent follow-up. This rapid turnaround meets newborn screening timeline standards.
4. What clinical information must accompany the sample?
Clinical details and drug history (including maternal medications during pregnancy, infant supplements, and any special formulas) must accompany the sample. The heel-prick blood is collected on three spots of filter paper provided by the laboratory; the sample must be refrigerated or frozen immediately after drying and shipped via cold chain.
UAE Regulatory & Data Privacy Adherence
This diagnostic service complies with all applicable UAE federal regulations. Patient data is processed and stored in full accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent procedures are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | Newborn Screening Panel 7 |
| Price (AED) | 450 AED |
| Turnaround Time | Next-day report (Mon-Fri collection by 9 AM) |
| Sample Type / Matrix | Heel-prick blood on filter paper (3 spots) |
| Methodology Used | Time-resolved Fluoroimmunoassay (FEIA) with confirmatory specialized immunoassays; supplemental LC-MS/MS available upon clinical indication |
| ICD-10-CM Code | E70.0, E71.0, E74.01 |
| LOINC Code | 54089-8 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians